Procter & Gamble Health Ltd banner

Procter & Gamble Health Ltd
NSE:PGHL

Watchlist Manager
Procter & Gamble Health Ltd Logo
Procter & Gamble Health Ltd
NSE:PGHL
Watchlist
Price: 5 172.5 INR -5.66% Market Closed
Market Cap: ₹85.9B

Operating Margin

32.5%
Current
Improving
by 6.2%
vs 3-y average of 26.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
32.5%
=
Operating Income
₹3.1B
/
Revenue
₹9.5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
32.5%
=
Operating Income
₹3.1B
/
Revenue
₹9.5B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Procter & Gamble Health Ltd
NSE:PGHL
85.9B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
986.4B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
586.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
286.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
235.3B GBP
Loading...
CH
Novartis AG
SIX:NOVN
239B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
301.2B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
157.3B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
123.4B USD
Loading...

Market Distribution

Higher than 91% of companies in India
Percentile
91th
Based on 5 437 companies
91th percentile
32.5%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Procter & Gamble Health Ltd
Glance View

Market Cap
85.9B INR
Industry
Pharmaceuticals

In the vast landscape of healthcare, Procter & Gamble Health Ltd. carves its niche by blending science with daily life, transforming mundane routines into healthier lifestyles. Originally known for its parent company’s deep roots in consumer goods, P&G Health Ltd. has transitioned seamlessly into the pharmaceutical domain, focusing on over-the-counter (OTC) health products and supplements. Its journey is one of leveraging brand trust and an extensive distribution network to ensure that essential health solutions are accessible to consumers around the globe. P&G Health's emphasis on consumer awareness and education propels its growth, as it capitalizes on the modern consumer’s desire for self-care and proactive health management. At the heart of its business model lies a portfolio of products that spans various health categories, encapsulating vitamins, minerals, and supplements that address widespread health needs such as digestive wellness and immunity. The company thrives on innovation and strategic collaboration, utilizing a mix of in-house research alongside partnerships to remain at the forefront of consumer health trends. Revenue streams are buoyed by the strength of its established global market presence and regional expertise, ensuring adaptability across diverse economic landscapes. By catering to both established and emerging markets, Procter & Gamble Health Ltd. sustains its growth momentum, continuously refining its product offerings to meet the dynamic demands of health-conscious consumers.

PGHL Intrinsic Value
3 217.94 INR
Overvaluation 38%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
32.5%
=
Operating Income
₹3.1B
/
Revenue
₹9.5B
What is Procter & Gamble Health Ltd's current Operating Margin?

The current Operating Margin for Procter & Gamble Health Ltd is 32.5%, which is above its 3-year median of 26.3%.

How has Operating Margin changed over time?

Over the last 3 years, Procter & Gamble Health Ltd’s Operating Margin has increased from 22.3% to 32.5%. During this period, it reached a low of 22.3% on Sep 30, 2022 and a high of 32.6% on Mar 31, 2025.

Back to Top